Changes in Hong Kong stocks | Yun Zhisheng (09678) GaoKai nearly 3% officially released the U2-Med Three Medical University Model and recently signed several major model projects for the top three hospitals

The Zhitong Finance App learned that Yun Zhisheng (09678) opened nearly 3% higher. As of press release, it rose 2.46% to HK$74.85, with a turnover of HK$559,900.

According to the news, Yun Zhisheng issued an announcement. Recently, the company completed an iterative upgrade of the medical model based on the U2 base model, and officially released the industry's first major professional model “U2-Med Three Medical Models” (this upgrade) for the medical, medical insurance (including commercial insurance), and pharmaceutical fields. This upgrade further consolidates the company's model capabilities in the field of expertise and continues to promote technical iteration in high-value token scenarios. This model is expected to be widely embedded in core processes related to the digital collaboration of the three medical doctors, help accelerate the expansion of the company's large-scale model business, and form long-term and sustainable revenue contributions. In the MedBench evaluation in July 2026, the U2-Med series model ranked first in both the full-modal large model and smart device lists.

It is worth mentioning that recently, the company has successively won a number of artificial intelligence medical construction projects for the top three hospitals in China, covering regional benchmark medical institutions such as Beijing You'an Hospital affiliated to Capital Medical University, the Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), and Nanjing Tongren Hospital. The implementation of these benchmark projects not only enabled the company to continue to consolidate its core competitive advantage in high-end market competition, but also marked the commercialization of the company's medical model into a new stage of large-scale replication. The series of landing orders fully confirms that our medical model has formed a mature, complete, standardized, and large-scale delivery system that can be quickly replicated on a large scale. It can quickly adapt to the intelligent construction needs of different departments and types of hospitals, and set a benchmark example for the commercial implementation of domestic medical models.